JP2002510690A - アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物 - Google Patents

アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物

Info

Publication number
JP2002510690A
JP2002510690A JP2000542323A JP2000542323A JP2002510690A JP 2002510690 A JP2002510690 A JP 2002510690A JP 2000542323 A JP2000542323 A JP 2000542323A JP 2000542323 A JP2000542323 A JP 2000542323A JP 2002510690 A JP2002510690 A JP 2002510690A
Authority
JP
Japan
Prior art keywords
compound
pyridyl
aza
tricyclo
decane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000542323A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002510690A5 (enExample
Inventor
ベンケリフ，メロアン
リッピエロ，パトリック・マイケル
クルックス，ピーター・アンソニー
パーク，ヘイル
バッティ，バルウィンダー・シング
コールドウェル，ウィリアム・スコット
ダル，ゲイリー・モーリス
Original Assignee
アール・ジェイ・レイノルズ・タバコ・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/053,937 external-priority patent/US6057446A/en
Priority claimed from US09/054,175 external-priority patent/US5952339A/en
Application filed by アール・ジェイ・レイノルズ・タバコ・カンパニー filed Critical アール・ジェイ・レイノルズ・タバコ・カンパニー
Publication of JP2002510690A publication Critical patent/JP2002510690A/ja
Publication of JP2002510690A5 publication Critical patent/JP2002510690A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2000542323A 1998-04-02 1999-03-03 アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物 Pending JP2002510690A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/053,937 US6057446A (en) 1998-04-02 1998-04-02 Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US09/054,175 1998-04-02
US09/054,175 US5952339A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US09/053,937 1998-04-02
PCT/US1999/004728 WO1999051602A1 (en) 1998-04-02 1999-03-03 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
JP2002510690A true JP2002510690A (ja) 2002-04-09
JP2002510690A5 JP2002510690A5 (enExample) 2006-05-11

Family

ID=26732410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000542323A Pending JP2002510690A (ja) 1998-04-02 1999-03-03 アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物

Country Status (13)

Country Link
EP (1) EP1068208B1 (enExample)
JP (1) JP2002510690A (enExample)
KR (1) KR100591805B1 (enExample)
AT (1) ATE240331T1 (enExample)
AU (1) AU2892999A (enExample)
BR (1) BR9907172A (enExample)
CA (1) CA2317567A1 (enExample)
DE (1) DE69907894T2 (enExample)
DK (1) DK1068208T3 (enExample)
ES (1) ES2199561T3 (enExample)
MX (1) MXPA00009634A (enExample)
PT (1) PT1068208E (enExample)
WO (1) WO1999051602A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
MY137020A (en) * 2000-04-27 2008-12-31 Abbott Lab Diazabicyclic central nervous system active agents
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
WO2001082978A2 (en) * 2000-05-01 2001-11-08 Targacept, Inc. Imaging of nicotinic acetylcholine receptor subtypes
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
EP2069346B1 (en) 2007-03-23 2011-12-21 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
CA2679876A1 (en) * 2007-03-23 2008-10-02 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
CA2809675A1 (en) 2010-09-23 2012-03-29 Shuang Chen Monohydrate of an azaadamantane derivative
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
JP3510937B2 (ja) * 1995-06-05 2004-03-29 ポリプラスチックス株式会社 耐熱性ポリエステルアミドスルフィド樹脂及びその組成物
JPH11508540A (ja) * 1995-06-29 1999-07-27 ノボ ノルディスク アクティーゼルスカブ 新規の置換アザ環式またはアザ二環式化合物
JPH11512443A (ja) * 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ 新規な置換アザ環式またはアザ二環式化合物

Also Published As

Publication number Publication date
DK1068208T3 (da) 2003-09-01
CA2317567A1 (en) 1999-10-14
EP1068208A1 (en) 2001-01-17
WO1999051602A1 (en) 1999-10-14
MXPA00009634A (es) 2005-06-20
BR9907172A (pt) 2000-10-10
PT1068208E (pt) 2003-09-30
ES2199561T3 (es) 2004-02-16
EP1068208B1 (en) 2003-05-14
AU2892999A (en) 1999-10-25
ATE240331T1 (de) 2003-05-15
KR20010052173A (ko) 2001-06-25
KR100591805B1 (ko) 2006-06-26
DE69907894T2 (de) 2004-03-11
DE69907894D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
US5952339A (en) Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
USRE41439E1 (en) Pharmaceutical compositions and methods for use
US6432975B1 (en) Pharmaceutical compositions and methods for use
US6057446A (en) Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
JP2002510690A (ja) アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物
JP2002510689A (ja) アザトリシクロ化合物
EP0994875B1 (en) 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders
JP2003513054A (ja) アリールオレフィンアザ環式化合物及びアリールアセチレンアザ環式化合物、それらを含有する薬剤組成物、及び、ニコチンコリン作動性受容体の阻害薬としてのそれらの使用
US6579878B1 (en) Pharmaceutical compositions and methods for use
US6890935B2 (en) Pharmaceutical compositions and methods for use
MXPA00007844A (en) Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040921

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040921

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090901

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100216